Compounding Pharmacy Solutions is an authorized DME supplier for medicare equipments and products.
Compounding Pharmacy Solutions is a Home Infusion Therapy Pharmacy in Houston, Texas. It is located at 6105 Beverly Hill Street, Suite 201, Houston and it's customer support contact number is 713-783-2836. The authorized person of Compounding Pharmacy Solutions is Mr. Abdallah Rassy, R.PH. who is Pharmacist of the pharmacy and his contact number is 713-783-2836. Active license number of Compounding Pharmacy Solutions is 27496 for Home Infusion Therapy Pharmacy in Texas. Compounding Pharmacy Solutions accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Compounding Pharmacy Solutions is pharmacy-based, decentralized patient care organization with expertise in USP 797-compliant sterile drug compounding that provides care to patients with acute or chronic conditions generally pertaining to parenteral administration of drugs, biologics and nutritional formulae administered through catheters and/or needles in home and alternate sites. Extensive professional pharmacy services, care coordination, infusion nursing services, supplies and equipment are provided to optimize efficacy and compliance.
Pharmacy Details:
Compounding Pharmacy Solutions type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Compounding Pharmacy Solutions
Type:
Home Infusion Therapy Pharmacy
Location:
6105 Beverly Hill Street, Suite 201, Houston, Texas, 77057-6716
Phone:
713-783-2836
Fax:
713-782-2644
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Mr. Abdallah Rassy
Credentials:
R.PH.
Position:
Pharmacist
Contact Number:
713-783-2836
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1043503915
NPI Enumeration Date:
25 May, 2011
NPI Last Update On:
18 Mar, 2013
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Compounding Pharmacy Solutions are as mentioned below.
Specialization
License Number
State
Status
Home Infusion Therapy Pharmacy
27496
Texas
Primary
Pharmacy
Secondary
Community/Retail Pharmacy
Secondary
Compounding Pharmacy
27496
Texas
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
5903249
Other
Ncpdp Provider Identification Number
Medicare Enrollment:
Compounding Pharmacy Solutions is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
6800051962
O20120625000030
Compounding Pharmacy Solutions
DME SUPPLIER - PHARMACY
Products Available:
Compounding Pharmacy Solutions has following products available for sale under medicare.
Products
Infusion Pumps & Supplies: External Infusion
Parenteral Equipment And/or Supplies
Parenteral Nutrients
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6105 Beverly Hill Street, Suite 201 Houston, Texas
Zip:
77057-6716
Phone Number:
713-783-2836
Fax Number:
713-782-2644
Patients can reach Compounding Pharmacy Solutions at 6105 Beverly Hill Street, Suite 201, Houston, Texas or can call on customer care at 713-783-2836.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.